Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 11/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | RARA | P10276 | 1/20 | 0.31 |
| ▸ | RARB | P10826 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21675468 | 1.00 | POLB (0.36) | POLBAPEX1HTTTDP1FFAR4 | |
| SCHEMBL20275159 | 0.95 | POLB (0.36) | POLBAPEX1HTTTDP1FFAR4 | |
| SCHEMBL16559840 | 0.93 | POLB (0.40) | POLBAPEX1HTTTDP1FFAR4 | |
| SCHEMBL17538614 | 0.90 | POLB (0.43) | POLBAPEX1HTTTDP1FFAR4 | |
| SCHEMBL19158978 | 0.89 | FFAR1 (0.40) | POLBAPEX1HTTTDP1FFAR4 | |
| SCHEMBL21675432 | 0.89 | POLB (0.39) | POLBAPEX1HTTTDP1 | |
| SCHEMBL22023580 | 0.89 | POLB (0.37) | POLBAPEX1HTTTDP1FFAR4 | |
| SCHEMBL16573113 | 0.88 | POLB (0.45) | POLBAPEX1HTTTDP1FFAR4 | |
| SCHEMBL20275179 | 0.88 | POLB (0.36) | POLBAPEX1HTTTDP1FFAR4 | |
| SCHEMBL19159115 | 0.86 | POLB (0.36) | POLBAPEX1HTTTDP1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11718791-B2 | Polymerisable compounds and the use thereof in liquid-crystal displays | MERCK PATENT GMBH (DE) | 2023-08-08 | — | — | US | disclosed |
| US-20210139781-A1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCK PATENT GMBH (DE) | 2021-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718791-B2 | Polymerisable compounds and the use thereof in liquid-crystal displays | VCL, ILK, LCP1 | POLB 3618/4885APEX1 3283/4885HTT 1781/4885 |
| US-20210139781-A1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | VCL, ILK, LCP1 | POLB 3618/4885APEX1 3283/4885HTT 1781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.